Robert Cascella - 30 Jun 2022 Form 4 Insider Report for KORU Medical Systems, Inc. (KRMD)

Reporting relationship: Director
Issuer ticker: KRMD
Reported as of: 30 Jun 2022
Net transaction value: +$9,232
SEC form: 4
Accepted by SEC: 05 Jul 2022, 18:15:53 UTC
Prior SEC filing: 17 Jun 2022
Next SEC filing: 03 Oct 2022
Source filing: View source filing
Reporting owner signature: /s/ Stephen Unger- Attorney-in-Fact

Key filing fact

Robert Cascella filed Form 4 for KORU Medical Systems, Inc. (KRMD) on 05 Jul 2022.

Key facts

This page summarizes Robert Cascella's Form 4 filing for KORU Medical Systems, Inc. (KRMD).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 Jul 2022, 18:15.

Change

Previous filing in this sequence was filed on 17 Jun 2022.
Current net transaction value: +$9,232.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KRMD transaction

Common Stock

Award

Transaction value: $9,232
Shares: +3,693
Change %
Price: $2.50
Shares after: 3,693
Date: 30 Jun 2022
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. Power of Attorney filed herewith as Exhibit 24.